CIFENLINE: 72 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
72
Total FAERS Reports
9 (12.5%)
Deaths Reported
42
Hospitalizations
72
As Primary/Secondary Suspect
13
Life-Threatening
2
Disabilities
First Report: 2003 · Latest Report: 20221201
What Are the Most Common CIFENLINE Side Effects?
#1 Most Reported
Hypoglycaemia
10 reports (13.9%)
#2 Most Reported
Orthostatic hypotension
7 reports (9.7%)
#3 Most Reported
Arrhythmia
7 reports (9.7%)
All CIFENLINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypoglycaemia | 10 | 13.9% | 1 | 7 |
| Arrhythmia | 7 | 9.7% | 2 | 4 |
| Orthostatic hypotension | 7 | 9.7% | 0 | 6 |
| Cardiac failure | 6 | 8.3% | 0 | 5 |
| Hepatocellular injury | 6 | 8.3% | 0 | 6 |
| Altered state of consciousness | 5 | 6.9% | 1 | 2 |
| Cholestasis | 5 | 6.9% | 0 | 5 |
| Condition aggravated | 5 | 6.9% | 1 | 4 |
| Hepatitis acute | 5 | 6.9% | 0 | 5 |
| Interstitial lung disease | 5 | 6.9% | 2 | 4 |
Who Reports CIFENLINE Side Effects? Age & Gender Data
Gender: 52.3% female, 47.7% male. Average age: 80.0 years. Most reports from: JP. View detailed demographics →
Is CIFENLINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 0 |
| 2013 | 3 | 0 | 1 |
| 2014 | 8 | 2 | 3 |
| 2015 | 5 | 2 | 1 |
| 2016 | 8 | 1 | 7 |
| 2017 | 7 | 1 | 7 |
| 2018 | 3 | 0 | 1 |
| 2019 | 3 | 1 | 0 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 1 |
What Is CIFENLINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 22 |
| Atrial fibrillation | 17 |
| Arrhythmia | 10 |
| Hypertrophic cardiomyopathy | 9 |
Official FDA Label for CIFENLINE
Official prescribing information from the FDA-approved drug label.